Molecular Partners AG
MOLN
$4.34
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | -91.14% | -67.23% | -27.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -100.00% | -91.14% | -67.23% | -27.77% |
| Cost of Revenue | -13.04% | -16.26% | -13.35% | -8.28% | 1.26% |
| Gross Profit | 2.89% | 4.83% | -0.96% | -1.09% | -6.24% |
| SG&A Expenses | -7.43% | -7.07% | -3.96% | -4.88% | -6.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.45% | -13.72% | -10.78% | -7.32% | -0.92% |
| Operating Income | 4.28% | 5.51% | 0.56% | 0.78% | -2.16% |
| Income Before Tax | -20.57% | -0.05% | -15.74% | -1.61% | 11.10% |
| Income Tax Expenses | 21.74% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.57% | -0.05% | -15.74% | -1.61% | 11.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.57% | -0.05% | -15.74% | -1.61% | 11.09% |
| EBIT | 4.28% | 5.51% | 0.56% | 0.78% | -2.16% |
| EBITDA | 4.28% | 5.58% | 0.49% | 0.71% | -2.16% |
| EPS Basic | -9.43% | 11.10% | -5.80% | 4.15% | 13.84% |
| Normalized Basic EPS | -4.62% | 15.23% | -1.50% | 4.16% | 13.85% |
| EPS Diluted | -9.30% | 11.00% | -5.91% | 4.04% | 13.74% |
| Normalized Diluted EPS | -4.62% | 15.23% | -1.50% | 4.16% | 13.85% |
| Average Basic Shares Outstanding | 9.51% | 12.45% | 9.57% | 6.65% | 3.85% |
| Average Diluted Shares Outstanding | 9.51% | 12.45% | 9.57% | 6.65% | 3.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |